SpyGlass Pharma Reports GAAP EPS of -$5.72
SpyGlass Pharma, Inc. has released its financial results, reporting a GAAP Earnings Per Share of -$5.72.
8 stories found
SpyGlass Pharma, Inc. has released its financial results, reporting a GAAP Earnings Per Share of -$5.72.

Ghostface’s still got it. “Scream 7,” the latest installment in Paramount and Spyglass Media’s long-running slasher series, cemented a franchise record with $64.1 million in its domestic box office…

Protestors took to the streets to show their support for Palestine amid the Scream 7 premiere at Paramount Pictures Studios in Los Angeles. “Paramount has a BLACKLIST of actors who criticize Israel,” read one side of a sign by an activist, with the other sign urging people to “Cancel Paramount+.” In November 2023, Spyglass Media […]

EXCLUSIVE: Mark Korshak has joined the recently launched production and finance company Giovanni Entertainment in the newly created role of Chief Media Officer. Korshak joins following four years as CEO of Artists Road, a joint venture between Spyglass Media Group, Propagate Content, Artists First and Off-Road Productions, where he led development, production, and sales strategy […]

Ghostface is back to wreak havoc on Woodsboro and the box office with “Scream 7,” the latest entry in Paramount and Spyglass’ horror series.

Paramount and Spyglass's 'Scream 7' is expected to achieve a global debut of over $60 million, marking the horror franchise's second-best opening.

Paramount/Spyglass’ Scream 7 scored the best opening year to date for a Hollywood movie with $97.2M at the global weekend box office.

EXCLUSIVE: After becoming the lead bidder for Warner Bros Discovery, Paramount is capping off a great Thursday with $7.5M in previews for the Spyglass co-production, Scream 7, which would rep a…